Search Results - "Montaño Figueroa, Efreen"
-
1
Experiences with health care and health-related quality of life of patients with hematologic malignancies in Mexico
Published in BMC health services research (10-07-2020)“…In Mexico, patients with hematologic malignancies (HMs) are characterized by being at high risk and advanced stages at diagnosis and by having a low cure rate;…”
Get full text
Journal Article -
2
Cardiac effects of deferasirox in transfusion‐dependent patients with myelodysplastic syndromes: TELESTO study
Published in British journal of haematology (01-05-2024)“…Summary Iron overload from repeated transfusions has a negative impact on cardiac function, and iron chelation therapy may help prevent cardiac dysfunction in…”
Get full text
Journal Article -
3
Activity and safety of eltrombopag in combination with cyclosporin A as first‑line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study
Published in The Lancet. Haematology (01-03-2024)“…Antithymocyte globulin (ATG)-based immunosuppression is standard in front-line treatment for people with severe aplastic anaemia without a histocompatible…”
Get full text
Journal Article -
4
-
5
Acute leukemia characteristics are different around the world: the Mexican perspective
Published in Clinical lymphoma, myeloma and leukemia (01-01-2017)“…Abstract Background The incidence of acute leukemia (AL) has increased. Its prognosis is variable and depends on several baseline characteristics with a highly…”
Get full text
Journal Article -
6
Overexpression of BCL2 , BCL6 , VEGFR1 and TWIST1 in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival
Published in OncoTargets and therapy (01-01-2022)“…Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous malignant lymphoid neoplasm and is the most common subtype of non-Hodgkin lymphoma in adults. More…”
Get full text
Journal Article -
7
Comparison of the Hyper-CVAD with an institutional regimen for the treatment of acute lymphoblastic leukemia in adults in a hospital of Mexico
Published in Revista peruana de medicina experimental y salud pública (01-07-2014)“…In order to assess the mortality and toxicity of the Hyper-CVAD protocol used as first-line treatment of acute lymphoblastic leukemia, a retrospective cohort…”
Get full text
Journal Article -
8
Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes: A Randomized Trial
Published in Annals of internal medicine (21-04-2020)“…Iron chelation therapy (ICT) in patients with lower-risk myelodysplastic syndromes (MDS) has not been evaluated in randomized studies. To evaluate event-free…”
Get full text
Journal Article -
9
Understanding factors limiting hematopoietic cell transplantation for acute myeloid leukemia patients in Mexico: a comprehensive analysis
Published in Annals of hematology (01-10-2024)“…Acute myeloid leukemia (AML) is the most frequent indication for allogeneic hematopoietic cell transplantation (alloHCT) worldwide; social and health system…”
Get full text
Journal Article -
10
-
11
Acute Myeloid Leukemia in Mexico: The Specific Challenges of a Developing Country. Results From a Multicenter National Registry
Published in Clinical lymphoma, myeloma and leukemia (01-06-2020)“…In the past decades, long-term survival outcomes for younger patients with acute myeloid leukemia (AML) have improved. Nonetheless, developing nations might be…”
Get full text
Journal Article -
12
Efficacy and Safety of Eltrombopag Combined with Cyclosporine As First-Line Therapy in Adults with Severe Acquired Aplastic Anemia: Results of the Interventional Phase 2 Single-Arm Soar Study
Published in Blood (23-11-2021)“…Background: Severe aplastic anemia (SAA) is a rare bone marrow failure disorder associated with significant morbidity and mortality. SAA is characterized by…”
Get full text
Journal Article -
13
Linfomas en la era COVID-19
Published in Gaceta médica de México (28-03-2023)Get full text
Journal Article -
14
-
15
Clinicopathological Features and Outcomes of EBV Positive and Negative DLBCL: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)
Published in Blood (23-11-2021)“…Introduction: Studies conducted in the pre-rituximab era found EBV positive diffuse large B-cell lymphoma (EBV+ DLBCL) as a disctinct entity carrying a dismal…”
Get full text
Journal Article -
16
A Novel Prognostic Index for Patients with EBV-DLBCL NOS: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)
Published in Blood (23-11-2021)“…Introduction: Epstein Barr virus-positive (EBV+) diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) is a newly recognized entity by the World…”
Get full text
Journal Article -
17
Tissue Factor Expression As a Prognostic Marker in Patients with B-Cell Malignant Lymphoma
Published in Blood (08-12-2017)“…Background. Studies in tumor cell lines have shown an increased expression of TF. Expression of TF in adenocarcinoma of the pancreas is associated with tumor…”
Get full text
Journal Article -
18
Safety and Efficacy, Including Event-Free Survival, of Deferasirox Versus Placebo in Iron-Overloaded Patients with Low- and Int-1-Risk Myelodysplastic Syndromes (MDS): Outcomes from the Randomized, Double-Blind Telesto Study
Published in Blood (29-11-2018)“…▪ Background: MDS comprise a group of disorders characterized by bone marrow (BM) failure, cytogenetic and molecular alterations, and progression to acute…”
Get full text
Journal Article -
19
-
20
Effect of Metformin in Patients with ALL Who Express High Levels of the ABCB1 Gene and Its Impact on Survival
Published in Blood (08-12-2017)“…OBJECTIVES. In acute lymphoblastic leukemia (ALL), high levels ABCB1 gene expression have been associated with treatment resistance. Metformin has been…”
Get full text
Journal Article